You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MET pathway

Showing 1 - 25 of 4,364
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 16, 2022

Advanced Hepatocellular Carcinoma With c-MET Dysregulation Trial in Worldwide (INC280)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma With c-MET Dysregulation
  • Nanjing, Jiangsu, China
  • +7 more
Jan 12, 2023

Evaluating the Chain of Addiction Care (CAC)

Recruiting
  • Hepatitis C, Chronic
  • Substance Use Disorders
    • Nijmegen, Gelderland, Netherlands
      Radboudumc
    May 31, 2022

    Kidney Cancer Trial run by the NCI (INC280)

    Completed
    • Kidney Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 18, 2021

    Malignant Non-small Cell Tumor of Lung Stage IV Trial in Boston (Capmatinib (INC280))

    Completed
    Has Results
    • Malignant Non-small Cell Neoplasm of Lung Stage IV
    • Capmatinib (INC280)
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 11, 2022

    Resistance-associated Mutations in Metastatic Lung Cancer

    Recruiting
    • Lung Cancer
    • Liquid biopsy
    • Monza, MB, Italy
      Fondazione IRCCS San Gerardo dei Tintori
    Oct 10, 2023

    NSCLC Trial in Worldwide (Osimertinib + Savolitinib, Savolitinib + Placebo)

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • Osimertinib + Savolitinib
    • Savolitinib + Placebo
    • Duarte, California
    • +20 more
    Dec 2, 2022

    Lower Ureteric Stones, Medical Expulsive Therapy, Tadalafil Trial in Benha (Placebo, Silodosin, Tadalafil)

    Completed
    • Lower Ureteric Stones
    • +3 more
    • Placebo
    • +3 more
    • Benha, Egypt
      Benha University Hospitals
    Mar 29, 2023

    Tabrecta® (Capmatinib) in South Korea

    Not yet recruiting
    • Non-Small-Cell Lung Carcinoma
    • Capmatinib
    • (no location specified)
    Jan 19, 2023

    All-in-One Prostate Cancer Staging With MRI

    Recruiting
    • Prostate Cancer
    • Prostate Cancer Patients
    • Brescia, BS, Italy
    • +2 more
    Oct 3, 2023

    Anxiety, Depression, Cardiac Rehabilitation Trial in Manchester

    Recruiting
    • Anxiety
    • +2 more
      • Manchester, United Kingdom
        Manchester University NHS Foundation Trust
      Jul 13, 2023

      NSCLC Trial in Worldwide (Capmatinib, Amivantamab)

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Orange, California
      • +40 more
      Aug 3, 2022

      ShorT Stay Aneurysm Repair Study

      Not yet recruiting
      • Abdominal Aortic Aneurysm Without Rupture
        • London, United Kingdom
          Imperial College London
        Aug 4, 2022

        Urothelial Cancer Trial in Spain (Niraparib plus Cabozantinib)

        Recruiting
        • Urothelial Cancer
        • Niraparib plus Cabozantinib
        • Barcelona, Cataluña, Spain
        • +10 more
        Feb 8, 2022

        Wrist Fracture, Scaphoid Fracture Trial in Lugano (fast track, normal pathway)

        Recruiting
        • Wrist Fracture
        • Scaphoid Fracture
        • fast track
        • normal pathway
        • Lugano, Ticino, Switzerland
          Ospedale Regionale di Lugano - ORL
        Mar 22, 2022

        Chest Pain Trial (Diagnostic and safety of a nursing pathway for the management of non-traumatic chest pain)

        Not yet recruiting
        • Chest Pain
        • Diagnostic and safety of a nursing pathway for the management of non-traumatic chest pain
        • (no location specified)
        Nov 20, 2023

        Breast Cancer, Non-metastatic, Newly Diagnosed Trial in Grenoble, Saint-Martin-d'Hères (alternative medicine education

        Not yet recruiting
        • Breast Cancer
        • +3 more
        • alternative medicine education consultation
        • Grenoble, France
        • +1 more
        Jul 12, 2022

        Serum Retinoic Acid Induced Protein 14 and Metastasis Associated

        Not yet recruiting
        • Breast Cancer
        • laboratory test (RAI14 and MACC-1 )
        • (no location specified)
        Oct 18, 2023

        Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 Trial in Houston (ABBV-399)

        Completed
        Has Results
        • Recurrent Squamous Cell Lung Carcinoma
        • Stage IV Squamous Cell Lung Carcinoma AJCC V7
        • Houston, Texas
          M D Anderson Cancer Center
        Sep 21, 2021

        Well Differentiated Pancreatic Endocrine Tumor Trial in Milano (Everolimus plus Octreotide LAR plus Metformin)

        Active, not recruiting
        • Well Differentiated Pancreatic Endocrine Tumor
        • Everolimus plus Octreotide LAR plus Metformin
        • Milano, Italy
          Fondazione IRCCS Istituto Tumori Milano
        Sep 3, 2021

        Cardiac Valve Disease, Aortic Valve Disease, Mitral Valve Disease Trial in Amsterdam (360-degree Virtual Reality Patient Tour,

        Recruiting
        • Cardiac Valve Disease
        • +3 more
        • 360-degree Virtual Reality Patient Tour
        • +2 more
        • Amsterdam, Noord Holland, Netherlands
          Academic Medical Center
        Aug 14, 2023

        Diastolic Dysfunction, Obesity Trial in Cairo (Metformin)

        Not yet recruiting
        • Diastolic Dysfunction
        • Obesity
        • Cairo, Egypt
          Cairo University Hospitals
        Apr 26, 2023

        Huntington Disease Trial in Montpellier (procedure, genetic, other)

        Recruiting
        • Huntington Disease
        • Brain MRI
        • +3 more
        • Montpellier, France
          University Hospital of Montpellier
        Dec 23, 2021

        Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

        Recruiting
        • Pancreatic Ductal Adenocarcinoma
        • +5 more
        • Boston, Massachusetts
        • +4 more
        May 25, 2022

        Renal Failure to be Supported asPriority in Care Pathway in

        Not yet recruiting
        • Renal Failure
        • consultation
        • Corbeil-essonnes Cedex, France
          Centre Hospitalier Sud Francilien
        Sep 19, 2023